One thing in the presentation that I hadn't noticed before:
The lung cancer preclinical (which is probably being partnered) will be Zantrene + PD-1 inhibitor.
Phil has improved out of sight from the early days.
I'm not sure of the target audience. If I was new to RAC, this presentation wouldn't sell it to me by itself. The story takes many days of full-time DD for a new investor. But it's fine if the aim is to persuade existing investors to top up, e.g. in the SPP.
- Forums
- ASX - By Stock
- RAC
- Ann: Race investor briefing & updated presentation
Ann: Race investor briefing & updated presentation, page-299
-
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.49 |
Change
-0.015(1.00%) |
Mkt cap ! $255.5M |
Open | High | Low | Value | Volume |
$1.50 | $1.51 | $1.49 | $49.15K | 32.80K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 18 | $1.49 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.50 | 500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 18 | 1.490 |
3 | 1825 | 1.480 |
2 | 17265 | 1.475 |
1 | 950 | 1.470 |
2 | 1756 | 1.465 |
Price($) | Vol. | No. |
---|---|---|
1.495 | 500 | 1 |
1.500 | 14604 | 2 |
1.510 | 556 | 1 |
1.515 | 1 | 1 |
1.520 | 45 | 1 |
Last trade - 12.28pm 22/08/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O'Donovan, Executive Director
Gerard O'Donovan
Executive Director
SPONSORED BY The Market Online